Sarepta Therapeutics, Inc. SRPT Business Segments — Interest Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpense.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s business segments — interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s business segments — interest expense?
- Sarepta Therapeutics, Inc. (SRPT) reported business segments — interest expense of $21.71M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s business segments — interest expense changed year-over-year?
- Sarepta Therapeutics, Inc.'s business segments — interest expense increased by 382.2% year-over-year, from $4.5M to $21.71M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s business segments — interest expense?
- Over 3 years (2022 to 2025), Sarepta Therapeutics, Inc.'s business segments — interest expense has grown at a -10.5% compound annual growth rate (CAGR), from $53.25M to $38.14M.
- What does business segments — interest expense mean?
- The total cost of interest incurred on debt obligations specifically allocated to this business segment. It measures the financial burden of the segment's capital structure and leverage. High levels may indicate significant debt financing used to support segment operations or growth initiatives.